Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:2164-2169
Published online before print August 25, 2005, doi: 10.1161/01.ATV.0000183674.88817.fb
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
25/10/2164    most recent
01.ATV.0000183674.88817.fbv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masson, D.
Right arrow Articles by Assem, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masson, D.
Right arrow Articles by Assem, M.
Related Collections
Right arrowRelated Article
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:2164.)
© 2005 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Expression of the Pregnane X Receptor in Mice Antagonizes the Cholic Acid–Mediated Changes in Plasma Lipoprotein Profile

David Masson; Laurent Lagrost; Anne Athias; Philippe Gambert; Cynthia Brimer-Cline; Lubin Lan; John D. Schuetz; Erin G. Schuetz; Mahfoud Assem

From INSERM U498 (D.M., L.L., A.A., P.G.), Faculté de Médecine, Dijon, France; Pharmaceutical Sciences (C.B.-C., L.L., J.D.S., E.G.S., M.A.), St. Jude Children’s Research Hospital, Memphis, Tenn.

Correspondence to Dr Mahfoud Assem, Department of Pharmaceutical Sciences, St Jude Children’s Research Hospital, 332 N. Lauderdale Ave, Memphis, TN 38105-2794. E-mail Mahfoud.Assem{at}stjude.org

Objective— Modification of lipoprotein metabolism by bile acids has been mainly explained by activation of the farnesyl X receptor (FXR). The aim of the present study was to determine the relative contribution of the pregnane X receptor (PXR), another bile acid–activated nuclear receptor to changes in plasma lipoprotein profile.

Methods and Results— Wild-type mice, Pxr-deficient mice, and Pxr-null mice expressing human PXR (Pxr-null SXR-Tg mice) were fed a cholic acid–containing diet, and consequences on plasma lipoprotein profiles and target gene expression were assessed. Cholic acid produced significant decreases in high-density lipoprotein (HDL) cholesterol, plasma apolipoprotein (apo)A-I and hepatic apoA-I mRNA in wild-type mice. Interestingly, the effect of cholic acid was significantly more pronounced in Pxr-deficient mice, indicating that PXR contributes to the weakening of the effect of bile acids on lipoprotein metabolism. Reciprocally, changes in HDL/apoA-I profiles were abolished in Pxr-null SXR-Tg mice in which PXR-responsive genes, particularly those involved in bile acid detoxification were readily activated after cholic acid treatment.

Conclusion— PXR expression in mice antagonizes the cholic acid–mediated downregulation of plasma HDL cholesterol and apoA-I, and magnification of PXR/SXR-mediated changes may constitute a new mean to counteract the effects of bile acids on plasma lipoproteins.

To determine the contribution of PXR to the effect of bile acids on plasma lipoproteins, wild-type mice, PXR-deficient mice, and Pxr-null mice expressing human PXR were fed a cholic acid–containing diet. Mouse and human PXR were found to antagonize the cholic acid-mediated decreases in plasma HDL cholesterol and apoA-I.


Key Words: apolipoprotein A-I • bile acids • farnesyl X receptor • high-density lipoproteins • pregnane X receptor • steroid and xenobiotic receptor


Related Article:

A Role for the Pregnane X Receptor in High-Density Lipoprotein Metabolism
Gregory S. Shelness and Lawrence L. Rudel
Arterioscler. Thromb. Vasc. Biol. 2005 25: 2016-2017. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Lipid Res.Home page
T. Li, W. Chen, and J. Y. L. Chiang
PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine
J. Lipid Res., February 1, 2007; 48(2): 373 - 384.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. S. Shelness and L. L. Rudel
A Role for the Pregnane X Receptor in High-Density Lipoprotein Metabolism
Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2016 - 2017.
[Full Text] [PDF]